Susquehanna International Group
PPBT

Susquehanna International Group’s Purple Biotech PPBT Stock Holding History

Susquehanna International Group’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-65
Closed -$17.9K – 13273
2022
Q4 		$17.9K Buy
+65
New +$24.9K ﹤0.01% 11797
2022
Q3 		– Sell
-100
Closed -$48K – 13918
2022
Q2 		$48K Sell
100
-29
-22% -$17.4K ﹤0.01% 11996
2022
Q1 		$102K Sell
129
-12
-9% -$7.74K ﹤0.01% 11900
2021
Q4 		$110K Sell
141
-176
-56% -$150K ﹤0.01% 12076
2021
Q3 		$289K Buy
317
+130
+70% +$126K ﹤0.01% 10686
2021
Q2 		$183K Buy
+187
New +$172K ﹤0.01% 11686

Other funds holding PPBT

SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Susquehanna International Group's PPBT Position: Q1 2026 in Review

Susquehanna International Group increased its Purple Biotech (PPBT) stake by 14% in Q1 2026, buying an estimated $34.7K and bringing the position to 53,403 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #11539.

Susquehanna International Group first reported a position in PPBT in Q4 2017 and has held it in 12 quarters since. The position peaked at $309K in Q4 2025. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

  • Susquehanna International Group held 53,403 shares of Purple Biotech worth $216K as of Q1 2026.
  • Susquehanna International Group bought 6,426 Purple Biotech shares in Q1 2026, an estimated $34.7K.
  • Purple Biotech made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11539 holding.
  • Susquehanna International Group first reported a position in Purple Biotech in Q4 2017 and has held it in 12 quarters since.
  • Susquehanna International Group's Purple Biotech position peaked at $309K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.